Lise Voland

Lise Voland

Auto-generated profile, based on publicly available information

Lise Voland

Sorbonne Universite, Inserm, Nutrition and obesities: systemic approaches, Nutriomics, F-75013 Paris, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2022 in Gut Microbes
Verified
Journal Article
Open access
JDJean Debédat
Jean Debédat
TRTiphaine Le Roy
Tiphaine Le Roy
LVLise Voland
Lise Voland
EBEugeni BELDA
Eugeni BELDA
RARohia Alili
Rohia Alili
KCKarine Clément
Karine Clément
Roux-en-Y gastric bypass (RYGB) is efficient at inducing drastic albeit variable weight loss and type-2 diabetes (T2D) improvements in patients with severe obesity and T2D. We hypothesized a causal implication of the gut microbiota (GM) in these metabolic benefits, as RYGB is known to deeply impact its composition. In a cohort of 100 patients with baseline T2D who underwent RYGB and were followed for 5-years, we used a hierarchical clustering approach to stratify subjects based on the severity of their T2D (Severe vs Mild) throughout the follow-up. We identified via nanopore-based GM sequencing that the more severe cases of unresolved T2D were associated with a major increase of the class Bacteroidia, including 12 species comprising Phocaeicola dorei, Bacteroides fragilis, and Bacteroides caecimuris. A key observation is that patients who underwent major metabolic improvements do not harbor this enrichment in Bacteroidia, as those who presented mild cases of T2D at all times. In a separate group of 36 patients with similar baseline clinical characteristics and preoperative GM sequencing, we showed that this increase in Bacteroidia was already present at baseline in the most severe cases of T2D. To explore the causal relationship linking this enrichment in Bacteroidia and metabolic alterations, we selected 13 patients across T2D severity clusters at 5-years and performed fecal matter transplants in mice. Our results show that 14 weeks after the transplantations, mice colonized with the GM of Severe donors have impaired glucose tolerance and insulin sensitivity as compared to Mild-recipients, all in the absence of any difference in body weight and composition. GM sequencing of the recipient animals revealed that the hallmark T2D-severity associated bacterial features were transferred and were associated with the animals’ metabolic alterations. Therefore, our results further establish the GM as a key contributor to long-term glucose metabolism improvements (or lack thereof) after RYGB.

12 November 2021 in Obesity Reviews
Verified
Journal Article
Closed access
PDF file
LVLise Voland
Lise Voland
TRTiphaine Le Roy
Tiphaine Le Roy
JDJean Debédat
Jean Debédat
KCKarine Clément
Karine Clément

11 April 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ELEmilie Lefoulon
Emilie Lefoulon
NVNatalie Vaisman
Natalie Vaisman
HFHoracio M. Frydman
Horacio M. Frydman
LSLuo Sun
Luo Sun
LVLise Voland
Lise Voland
BSBarton E. Slatko
Barton E. Slatko
Symbiosis is a major force of evolutionary change, influencing virtually all aspects of biology, from population ecology and evolution to genomics and molecular/biochemical mechanisms of development and reproduction. A remarkable example is Wolbachia endobacteria, present in some parasitic nematodes and many arthropod species. Acquisition of genomic data from diverse Wolbachia clades will aid in the elucidation of the different symbiotic mechanisms(s). However, challenges of de novo assembly of Wolbachia genomes include the presence in the sample of host DNA: nematode/vertebrate or insect. We designed biotinylated probes to capture large fragments of Wolbachia DNA for sequencing using PacBio technology (LEFT-SEQ: Large Enriched Fragment Targeted Sequencing). LEFT-SEQ was used to capture and sequence four Wolbachia genomes: the filarial nematode Brugia malayi, wBm, (21-fold enrichment), Drosophila mauritiana flies (2 isolates), wMau (11-fold enrichment), and Aedes albopictus mosquitoes, wAlbB (200-fold enrichment). LEFT-SEQ resulted in complete genomes for wBm and for wMau. For wBm, 18 single-nucleotide polymorphisms (SNPs), relative to the wBm reference, were identified and confirmed by PCR. A limit of LEFT-SEQ is illustrated by the wAlbB genome, characterized by a very high level of insertion sequences elements (ISs) and DNA repeats, for which only a 20-contig draft assembly was achieved.

1 October 2023 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
LVLise Voland
Lise Voland
MYMeng Yuan
Meng Yuan
SLSimon Lecoutre
Simon Lecoutre
JDJean Debédat
Jean Debédat
VPVéronique Pelloux
Véronique Pelloux
KCKarine Clément
Karine Clément
This work investigates mechanisms involved in metabolic improvements induced by concomitant supplementation of prebiotic and biotin in a murine model of established obesity. We show that this strategy modulates lipid handling at the systemic and tissue level while alleviating inflammation and fibrosis of key tissues of obesity pathophysiology, such as adipose depots and liver. Our results provide meaningful insights for the translation of biotin and prebiotic supplementation into clinical studies.

8 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
PTPaul Taillandier
Paul Taillandier
LVLise Voland
Lise Voland
JDJean Debédat
Jean Debédat
AAAlix Archambeau
Alix Archambeau
SDSébastien Dussaud
Sébastien Dussaud
TRTiphaine Le Roy
Tiphaine Le Roy
The intestinal microbiota plays a pivotal role in regulating metabolic processes, and its imbalance is linked to metabolic disorders. Modulating the gut microbiota composition and function through prebiotic supplementation has been repeatedly shown to improve host metabolism. While most studies have focused on the fecal microbiota due to the ease of sampling, fecal samples do not reflect the microbial dynamics throughout the gastrointestinal tract, as regional environmental conditions shape distinct microbiota composition. Given the metabolic significance of the proximal intestine and the potential influence of microbiota on these processes, we characterized the microbiota composition along the gastrointestinal tract in a widely used model for studying host-microbiota interactions: C57Bl6J male mice fed a high-fat diet (HFD) with or without prebiotics supplementation (FOS, fructooligosaccharides). The microbiota composition, determined by long-read Nanopore sequencing, was markedly altered by HFD and FOS supplementation not only in feces but also in the jejunum, ileum and caecum. In contrast to previous observations made in humans, obesity in mice was associated with a decrease in microbiome diversity in the small intestine, highlighting species-specific microbial responses to metabolic challenges. Additionally, the pronounced bifidogenic effect of FOS supplementation in the ileum suggests FOS fermentation in the small intestine in mice, contrary to what has been previously described in humans. Finally, we report a relative homogeneity of microbiome composition along the digestive tract, possibly due to the coprophagic behavior of mice. These findings challenge the translational relevance of rodent models for studying the role of the small intestinal microbiota in human metabolic disease.

6 April 2026
Verified
Thesis
Closed access
LVLise Voland
Lise Voland
L’obésité est une maladie multifactorielle, à laquelle contribuent de nombreux facteurs, dont le microbiote intestinal. L’étude des fonctions qu’il assure est un élément clé de la compréhension des interactions bactéries/hôte. Ce potentiel fonctionnel s’opère par l’intermédiaire de métabolites parmi lesquelles on trouve les vitamines du groupe B. L’analyse de données métagénomiques a permis de mettre en évidence un déficit relatif en vitamine B7/B8 (biotine) au niveau de l’hôte et du microbiote intestinal en situation d’obésité sévère. En conduisant une série d’expériences chez la souris, nous avons démontré i) la contribution du microbiote dans la production de biotine, ii) le rôle du régime gras (HFD) dans l’altération du statut en biotine du microbiote et de l’hôte et iii) l’effet d’une supplémentation en biotine combinée à un prébiotique (FOS) dans le rétablissement du métabolisme vitaminique bactérien et l’amélioration des altérations métaboliques et tissulaires induites par le HFD. Par ailleurs, nous avons cherché à faciliter l’absorption de la biotine, altérée en situation d’inflammation comme observée dans l’obésité, via une action anti-inflammatoire intestinale (5-ASA). Le 5-ASA combiné au FOS, sous HFD, n’a pas permis de rétablir le métabolisme vitaminique, mais a entrainé une limitation importante des altérations métaboliques induites par ce régime. Nos différentes interventions ont donc mis en évidence l’importance de la prise en compte du statut vitaminique des patients en situation d’obésité sévère. Ces résultats renforcent l’intérêt de l’utilisation combinaisons de traitements, ciblant différents organes et voies métaboliques, dans l’obésité sévère.